Description
Hemagglutinin-1 (HA1) (98-106) is a B cell and T cell binding epitope of hemagglutinin that may be used in the development of an influenza vaccine.
Hemagglutinin-1 Peptide
Product ID H0100
Cas No. 92000-76-5
Purity ≥95%
| Product Unit Size | Cost | Quantity | Stock |
|---|
Product Info
| Cas No. | 92000-76-5 |
|---|---|
| Purity | ≥95% |
| Formula | C53H67N9O17 |
| Formula Wt. | 1102.18 |
| IUPAC Name | (3S)-3-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-carboxypropanoyl]amino]-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]-4-[[(2S)-1-[[(1S)-1-carboxyethyl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-4-oxobutanoic acid |
| Synonym | HA1 fragment 98-106, HA tag peptide, Influenza Hemagglutinin (HA) Peptide |
| Solubility | Soluble in water, DMSO. |
| Appearance | White to off white powder |
Shipping and Storage
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
Downloads
| MSDS | |
|---|---|
| Info Sheet |
References
Hatzifoti C, Heath AW. CD40-mediated enhancement of immune responses against three forms of influenza vaccine. Immunology. 2007 Sep;122(1):98-106. PMID: 17472718.